載入...

Second Generation Analogs of the Cancer Drug Clinical Candidate Tipifarnib for Anti-Chagas Disease Drug Discovery

We previously reported that the cancer drug clinical candidate tipifarnib kills the causative agent of Chagas disease, Trypanosoma cruzi, by blocking ergosterol biosynthesis at the level of inhibition of lanosterol 14α-demethylase. Tipifarnib is an inhibitor of human protein farnesyltransferase. We...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Kraus, James M., Tatipaka, Hari Babu, McGuffin, Sarah A., Chennamaneni, Naveen Kumar, Karimi, Mandana, Arif, Jenifer, Verlinde, Christophe L. M. J., Buckner, Frederick S., Gelb, Michael H.
格式: Artigo
語言:Inglês
出版: 2010
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2877169/
https://ncbi.nlm.nih.gov/pubmed/20429511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm9013136
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!